Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

Chartwell Rx Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has one hundred and sixty-one approved drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	107
Ingredients:	100
NDAs:	161

Drugs and US Patents for Chartwell Rx

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	040196-006	Sep 30, 1997		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Chartwell Rx	REPAGLINIDE	repaglinide	TABLET;ORAL	078555-002	Jan 22, 2014	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	087918-001	Dec 22, 1983		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Chartwell Rx	SPIRONOLACTONE	spironolactone	TABLET;ORAL	086809-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Chartwell Rx	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	040196-009	Jul 26, 2000		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Chartwell Rx	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	089837-001	Aug 18, 1988		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Merck

Mallinckrodt

AstraZeneca

Express Scripts

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.